NUVO Technology (@NUVO_Technology) — Twitter Score 10 out of 1000

NUVO Technology is a Web3 infrastructure project building an adaptive stablecoin settlement network designed to reduce capital inefficiency and payment friction in the crypto economy. NUVO Technology's Twitter Score is 9.7 out of 1000 as of September 2026, ranking #96,062 among 486,860 tracked accounts.

NUVO Technology was previously known as Matrix before rebranding in February 2023, and was co-founded by Caria Wei, who serves as CEO. The project was incubated by Metis, which also lists it as infrastructure deployed on its network and approved through the Metis Community Verified Projects program. A BLS Wallet integration announced through Metis at the time of the rebrand enabled applications using NuvoWallet to offer gasless transactions.

NUVO Technology's current product lineup centers on NUVO Settlement, a cross-chain liquidity infrastructure layer, and NUVO Verify, a non-custodial stablecoin receiving gateway. Its NuOrbit product offers bridge-free cross-chain execution infrastructure that keeps assets on their native chain while issuing settlement proofs for external applications. An earlier product suite called NuvoSphere encompassed NuvoOne middleware, NuvoMe wallets and profiles, NuvoID Web3 avatars, NuvoBadge digital credentials, and an Inscription Platform supporting token deployment, inscription minting, and transaction management across EVM-compatible blockchains.

NUVO Technology has also disclosed a security incident in which a social-engineering and impersonation attack briefly compromised the X accounts of co-founder Caria Wei and NuDEX, resulting in the promotion of a fake $NUDEX token; the project stated that no user funds or platform assets were affected. NUVO Technology has published 2,959 posts on the platform.

Who follows NUVO Technology on X?

The accounts that follow NUVO Technology include 33 founders, 5 angel investors, 56 influencers and 1 VCs, among them Ivan On Tech Head Trader Bullmania, Milk Road Crypto, Small Cap Scientist, Shah, Degenharambe and Mercek.